Treatment of MS with goat serum

Details for Australian Patent Application No. 2003202093 (hide)

Owner Aimsco Limited

Inventors Dalgleish, Angus G; Heeney, Jonathan; White, Stanley D T

Agent Griffith Hack

Pub. Number AU-B-2003202093

PCT Number PCT/GB03/00342

PCT Pub. Number WO2003/064472

Priority 0201896.8 28.01.02 GB; PCT/GB02/03037 02.07.02 GB

Parent 2002317285

Filing date 28 January 2003

Wipo publication date 2 September 2003

Acceptance publication date 13 May 2010

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/02 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 39/02 (2006.01) General protective or antinoxious agents

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

G06F 21/20 (2006.01) Security arrangements for protecting computers or computer systems against unauthorised activity

H04L 9/32 (2006.01) Arrangements for secret or secure communication - including means for verifying the identity or authority of a user of the system

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 0201896.8 28.01.02 GB; PCT/GB02/03037 02.07.02 GB

18 September 2003 Application Open to Public Inspection

  Published as AU-B-2003202093

12 August 2004 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 22 Jul 2004

29 April 2010 Amendment Made

  The nature of the amendment is: Add priority details under INID (62) 2002317285

13 May 2010 Application Accepted

  Published as AU-B-2003202093

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003202094-Quinazoline compounds

2003202092-Descent apparatus